SG 209
SG 209 structure
|
Common Name | SG 209 | ||
|---|---|---|---|---|
| CAS Number | 83440-03-3 | Molecular Weight | 208.21400 | |
| Density | 1.182g/cm3 | Boiling Point | 430.7ºC at 760 mmHg | |
| Molecular Formula | C10H12N2O3 | Melting Point | N/A | |
| MSDS | USA | Flash Point | 214.3ºC | |
Use of SG 209SG-209 is a potassium channel opener. |
| Name | SG 209,N-[2-(Acetoxy)ethyl]-3-pyridinecarboxamide |
|---|---|
| Synonym | More Synonyms |
| Density | 1.182g/cm3 |
|---|---|
| Boiling Point | 430.7ºC at 760 mmHg |
| Molecular Formula | C10H12N2O3 |
| Molecular Weight | 208.21400 |
| Flash Point | 214.3ºC |
| Exact Mass | 208.08500 |
| PSA | 68.29000 |
| LogP | 0.76540 |
| Index of Refraction | 1.521 |
| InChIKey | JQICNNKLTFYSLS-UHFFFAOYSA-N |
| SMILES | CC(=O)OCCNC(=O)c1cccnc1 |
| Personal Protective Equipment | Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
|---|---|
| Safety Phrases | 22-24/25 |
| RIDADR | NONH for all modes of transport |
| HS Code | 2933399090 |
|
~%
SG 209 CAS#:83440-03-3 |
| Literature: TERNANSKY, Robert Patent: WO2007/38772 A1, 2007 ; Location in patent: Example 2 ; WO 2007/038772 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
|
ATP-sensitive potassium channel activation induces angiogenesis in vitro and in vivo.
J. Pharmacol. Exp. Ther. 354 , 79-87, (2015) Intense research is conducted to identify new molecular mechanisms of angiogenesis. Previous studies have shown that the angiogenic effects of hydrogen sulfide (H2S) depend on the activation of ATP-se... |
|
|
Nicorandil inhibits degranulation and TNF-alpha release from RBL-2H3 cells.
Inflamm. Res. 51 , 176-181, (2002) Nicorandil is a potassium channel opener and nitric oxide (NO) donor, and the hypothesis was tested that these modes of action may inhibit cellular degranulation and release of tumour necrosis factor-... |
|
|
A further study of the vasodilator and negative inotropic mechanisms of action of nicorandil and its congeners in the canine heart.
Cardiovasc. Drugs Ther. 8 , 227-234, (1994) The vasodilator and negative inotropic mechanisms of action of nicorandil and its congeners (SG-209, SG-103, and SG-86) were investigated in isolated canine papillary muscle preparations cross-circula... |
| sg 209 |